Precision Medicine News and Research

RSS

Metabolites could be used as biomarkers for forensic diagnosis of diabetes mellitus

Determining the cause of death is one of the most crucial and challenging parts of a forensic investigation.

28 Feb 2022

Researchers develop new precision medicine technology for cancer immunotherapy

In recent years, great advances have been made in the development of new successful immunotherapies to treat cancer. CAR T-cell therapy and antibody treatments are two types of targeted immunotherapies that have revolutionized areas of cancer care.

28 Feb 2022

Computer model warns about the negative consequences of diabetes treatment for some cancers

Using computer drug simulations, researchers have found that doctors need to be wary of prescribing a particular treatment for all types of cancer and patients.

28 Feb 2022

Study identifies specific RNA biomarkers linked to gastrointestinal issues in kids with autism

As a clinician at the University of Missouri Thompson Center for Autism and Neurodevelopmental Disorders, David Beversdorf helps patients with autism spectrum disorder (ASD), many of whom may also be struggling with gastrointestinal or digestive issues, including constipation and diarrhea.

25 Feb 2022

Research could pave the way for adoption of precision medicine approaches for COVID-19

The COVID-19 pandemic has revealed a frightening reality; the course of infection with this disease is highly variable. Some young patients have died from the virus, whereas several elderly people have survived without experiencing respiratory symptoms at all. Researchers are left wondering: why?

25 Feb 2022

Genetic analysis reveals eosinophilic colitis as a unique disease

A condition called eosinophilic colitis is distinct from other, similar eosinophilic gastrointestinal diseases and inflammatory bowel disease, according to a genetic analysis published in Gastroenterology.

24 Feb 2022

Genetic mutation associated with perceived inadequate milk supply in mothers

Leading health care organizations recommend exclusive breastfeeding for six months after birth, yet some mothers report stopping due to a perceived lack of milk supply.

23 Feb 2022

Circulating miR-155 may predict chances of survival in hospitalized COVID-19 patients

Scientists from Israel have recently estimated the levels of circulating microRNAs (miRNAs) in hospitalized coronavirus disease 2019 (COVID-19) patients with the aim of identifying prognostic biomarkers for disease severity. They have identified miR-155, an important regulatory molecule in the immune system, as a potential biomarker to predict COVID-19 severity and mortality.

22 Feb 2022

Novel platform can become a potential approach for personalized cancer treatments

Killing cancer cells without affecting surrounding normal cells is the most desirable approach for targeted cancer therapy. However, it cannot be easily achieved due to the similarities in the properties between normal and cancer cells.

22 Feb 2022

SARS-CoV-2 Omicron variant prompts system sciences and precision medicine

In a new review study, researchers aimed to describe the emergence of the Omicron variant, its structure, its impact on health and health systems, and the challenges that can be expected due to this variant.

21 Feb 2022

Codiak's publication highlights the ability of exoASO-STAT6 to selectively target tumor-associated macrophages

Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced the online publication of a new manuscript, Exosome mediated genetic reprogramming of tumor associated macrophages by exoASO-STAT6 leads to potent monotherapy anti-tumor efficacy, in the American Association for the Advancement of Science's journal, Science Advances.

18 Feb 2022

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Joint study will assess clinical value of comprehensive genomic profiling (CGP) on cancer therapy options in patients with advanced disease

From Illumina, Inc. 17 Feb 2022

Study helps understand actionable genetic variation affecting drugs in the Middle East population

A group of researchers at Qatar Foundation have reported the first comprehensive study of the distribution of actionable genetic variation affecting drugs in any Middle Eastern population, with potential implications for preemptive pharmacogenomic implementation in the region.

16 Feb 2022

Study uncovers most critical genes that cause coronary heart disease

The most critical genes that cause coronary heart disease and trigger heart attacks have been identified in a major new study.

15 Feb 2022

Deep insights on digital transformation in health care

The COVID-19 pandemic sparked a digital transformation in health care. Artificial intelligence and the Internet of Things are contributing to widespread changes in medicine, as reviewed in a Special Issue on All Things Digital Transformation in the peer-reviewed OMICS: A Journal of Integrative Biology.

14 Feb 2022

Precision Medicine News and Research

Metabolites could be used as biomarkers for forensic diagnosis of diabetes mellitus

Researchers develop new precision medicine technology for cancer immunotherapy

Computer model warns about the negative consequences of diabetes treatment for some cancers

Study identifies specific RNA biomarkers linked to gastrointestinal issues in kids with autism

Research could pave the way for adoption of precision medicine approaches for COVID-19

Genetic analysis reveals eosinophilic colitis as a unique disease

Genetic mutation associated with perceived inadequate milk supply in mothers

Circulating miR-155 may predict chances of survival in hospitalized COVID-19 patients

Novel platform can become a potential approach for personalized cancer treatments

SARS-CoV-2 Omicron variant prompts system sciences and precision medicine

Codiak's publication highlights the ability of exoASO-STAT6 to selectively target tumor-associated macrophages

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Study helps understand actionable genetic variation affecting drugs in the Middle East population

Study uncovers most critical genes that cause coronary heart disease

Deep insights on digital transformation in health care

Showcasing STEM Women in Medical Science

New protocol for transplanting 3D cellular structures to regenerate damaged intestinal tissue

Gene variants associated with acute kidney injury in Black veterans hospitalized with COVID-19

Research reveals why Black women experience higher breast cancer mortality

NIH grant renewal will enable Nebraska scientist to advance research on virtual immune system

Event guide: The 4th Precision Medicine in Inflammatory Bowel Disease Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News